Watchlist Price Alert

Mirati Therapeutics Inc. (MRTX)

NASDAQ: MRTX · Real-Time Price · USD

58.70

-0.10 (-0.17%)

At close: Jan 22, 2024, 9:00 PM

Mirati Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-740.87M	-581.78M	-357.94M	-213.26M	-98.42M	-70.43M	-83.12M
Depreciation & Amortization	2.93M	1.78M	641K	249K	175K	184K	180K
Stock-Based Compensation	186.19M	113.5M	85.85M	55.54M	15.85M	6.79M	10.62M
Other Working Capital	-1.35M	-5.47M	-7.02M	-9.86M	693K	361K	-906K
Other Non-Cash Items	-8.72M	12.11M	-11.42M	-3.42M	-1.32M	-266K	7K
Deferred Income Tax	n/a	n/a	-4.88M	n/a	n/a	n/a	n/a
Change in Working Capital	-10.1M	65.59M	16.22M	13.16M	13.61M	-980K	4.29M
Operating Cash Flow	-570.57M	-388.8M	-271.53M	-147.73M	-70.1M	-64.71M	-68.02M
Capital Expenditures	-4.85M	-9.79M	-4.37M	-1.55M	-122K	-81K	-196K
Cash Acquisitions	-230.65M	579.11M	135.49M	174.59M	n/a	n/a	n/a
Purchase of Investments	-956.7M	-1.42B	-662.82M	-530.23M	-255.79M	-100.56M	-70.27M
Sales Maturities Of Investments	1.19B	843.62M	527.33M	355.64M	110.15M	91.99M	108.72M
Other Investing Acitivies	230.65M	-579.11M	-135.49M	-174.59M	-145.64M	-8.57M	38.45M
Investing Cash Flow	225.8M	-588.9M	-139.86M	-176.14M	-145.76M	-8.65M	38.26M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	166.94M	505.22M	1.25B	338.03M	140.85M	158.68M	2.65M
Financial Cash Flow	166.94M	505.22M	1.25B	338.03M	140.85M	158.68M	2.65M
Net Cash Flow	-177.82M	-472.48M	839.33M	14.16M	-75.01M	85.32M	-27.11M
Free Cash Flow	-575.42M	-398.6M	-275.9M	-149.28M	-70.22M	-64.79M	-68.21M